Stock search

Ticker or company name

Compare stocks

Market: US

  • AAgilent Technologies
  • DHRDanaher Corporation
  • TMOThermo Fisher Scientific

Add stock

Ticker or company

Summary

A
Agilent Technologies
$172,92Down −0,60%
Year: Up +18%
78/100Best scoreRatio would consider buying
Open stock page
DHR
Danaher Corporation
$229,91Down −1,33%
Year: Up +5%
61/100Ratio would watch
Open stock page
TMO
Thermo Fisher Scientific
$691,33Down −1,27%
Year: Up +21%
56/100Ratio would watch
Open stock page

Verdict

A has the best score (78). A grows revenue the fastest. DHR is the cheapest by forward P/E. A has the lowest debt load. A has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckA6 ✓ 2 — 1 ✕DHR3 ✓ 5 — 1 ✕TMO3 ✓ 3 — 2 ✕
P/E vs its history34,137,936,3
P/E vs industry34,137,936,3
Forward P/E26,025,325,5
Revenue growth, YoY+8,6%+5,5%+8,3%
EPS growth, YoY+18,7%+26,0%+9,5%
Net margin19,5%16,9%n/a14,9%
Net debt / EBITDA1,03,13,6
Free cash flow$1,27 bn$5,73 bn$7,60 bn
Share count over a year−0,7%−1,0%−1,9%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterATTMDHRTTMTMOTTMIndustry medianTTM
P/E TTM ↓Best: 34,1Worst: 37,936,337,9
Forward P/E ↓Worst: 26,0Best: 25,325,529,5
PEG ↓Best: 3,7Worst: 4,23,83,7
P/S TTM ↓Worst: 6,76,4Best: 5,46,6
EV/EBITDA ↓Best: 26,8Worst: 30,729,529,9
P/FCF ↓Worst: 38,7Best: 28,633,838,7

Price, %

  • An/a
  • DHRn/a
  • TMOn/a

Returns

Best WorstNo mark — in between

PeriodADHRTMO
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

ADHRTMO
Share of “buy”Worst: 73%Best: 84%79%
Beat the forecastWorst: 2 of 4Best: 4 of 4Best: 4 of 4
Average “surprise”Worst: +1,6%Best: +5,4%+2,9%
Insiders over 12 monthssales $1,30 msales $36,7 msales $135 m

Details are on each stock page.